Phase II randomized trial comparing high-dose cisplatin with moderate- dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 12, Issue 2, 1994, Pages 353-359

  Sculier, J P ^a   Klastersky, J ^a   Giner, V ^a   Bureau, G ^a   Thiriaux, J ^a   Dabouis, G ^a   Efremidis, A ^a   Ries, F ^a   Berchier, M C ^a   Sergysels, R ^a   Mommen, P ^a   Paesmans, M ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; HYPOACUSIS; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; VOMITING;

EID: 0028158537     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1994.12.2.353     Document Type: Article

References (0)